Advertisement

Topics

New biomarkers for response to immunotherapy

10:28 EDT 4 Jul 2017 | ecancermedicalscience

Prof Ribas speaks with ecancer at WIN 2017 about "the canary in the mine" of PDL-1 expression on tumour cells, and their response to checkpoint therapy. He notes the off-target toxicities of ipilimumab, and the rationale for combining therapies to...

Original Article: New biomarkers for response to immunotherapy

NEXT ARTICLE

More From BioPortfolio on "New biomarkers for response to immunotherapy"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Monoclonal antibodies MAbs
Monoclonal antibodies recognise and attach to specific proteins produced by cells.  Types of monoclonal antibodies used to treat cancer cells: Block cell dividing dividing signals Transport cancer drugs or radiation to cancer cells Tr...